Empowered Funds LLC Invests $253,000 in Enovis Co. (NYSE:ENOV)

Empowered Funds LLC purchased a new position in Enovis Co. (NYSE:ENOV – Free Report) in the fourth quarter, Holdings Channel reports. The fund purchased 5,766 shares of the company’s stock, valued at approximately $253,000. Other hedge funds have also made changes to their positions in the company. UMB Bank n.a. lifted its position in shares [...]

featured-image

Empowered Funds LLC purchased a new position in Enovis Co. ( NYSE:ENOV – Free Report ) in the fourth quarter, Holdings Channel reports. The fund purchased 5,766 shares of the company’s stock, valued at approximately $253,000.

Other hedge funds have also made changes to their positions in the company. UMB Bank n.a.



lifted its position in shares of Enovis by 128.2% in the fourth quarter. UMB Bank n.

a. now owns 778 shares of the company’s stock worth $34,000 after purchasing an additional 437 shares in the last quarter. Pinnacle Bancorp Inc.

increased its holdings in Enovis by 54.5% in the fourth quarter. Pinnacle Bancorp Inc.

now owns 850 shares of the company’s stock worth $37,000 after buying an additional 300 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new position in Enovis in the third quarter worth approximately $55,000. FMR LLC increased its holdings in Enovis by 20.

5% in the third quarter. FMR LLC now owns 2,840 shares of the company’s stock worth $122,000 after buying an additional 484 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in Enovis in the third quarter worth approximately $217,000.

98.45% of the stock is owned by hedge funds and other institutional investors. Enovis Trading Down 2.

6 % NYSE:ENOV opened at $42.77 on Friday. Enovis Co.

has a 52 week low of $38.27 and a 52 week high of $65.03.

The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.

27. The stock’s 50 day moving average price is $45.08 and its 200 day moving average price is $44.

33. The company has a market capitalization of $2.43 billion, a P/E ratio of -19.

53 and a beta of 1.94. Analyst Upgrades and Downgrades Check Out Our Latest Stock Analysis on Enovis Enovis Profile ( Free Report ) Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide.

It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Featured Articles Want to see what other hedge funds are holding ENOV? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Enovis Co. ( NYSE:ENOV – Free Report ). Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.

com's FREE daily email newsletter ..